Literature DB >> 21653965

Vaccine supply chains need to be better funded and strengthened, or lives will be at risk.

Judith R Kaufmann1, Roger Miller, James Cheyne.   

Abstract

In the next decade, at least twelve additional vaccines that target such diseases as typhoid, malaria, and dengue will become available to lower- and middle-income countries. These vaccines must travel along what are called supply chains, which include all personnel, systems, equipment, and activities involved in ensuring that vaccines are effectively delivered from the point of production to the people who need them. But for various reasons, supply chains are already strained in many developing countries, and the potential inability to distribute new vaccines will place lives at risk. Among the many steps needed to strengthen the global vaccine supply chain, we suggest that the international community pursue improved coordination between organizations that donate and ship vaccines and the host-country officials who receive and distribute the vaccines, as well as better training for supply-chain managers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653965     DOI: 10.1377/hlthaff.2011.0368

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  20 in total

1.  Only adding stationary storage to vaccine supply chains may create and worsen transport bottlenecks.

Authors:  Leila A Haidari; Diana L Connor; Angela R Wateska; Shawn T Brown; Leslie E Mueller; Bryan A Norman; Michelle M Schmitz; Proma Paul; Jayant Rajgopal; Joel S Welling; Jim Leonard; Erin G Claypool; Yu-Ting Weng; Sheng-I Chen; Bruce Y Lee
Journal:  J Public Health Manag Pract       Date:  2013 Sep-Oct

2.  Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes.

Authors:  Osman David Mansoor; Debra Kristensen; Andrew Meek; Simona Zipursky; Olga Popova; Olga Popovaa; InderJit Sharma; Gisele Miranda; Jules Millogo; Heidi Lasher
Journal:  Bull World Health Organ       Date:  2012-11-05       Impact factor: 9.408

3.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

Review 4.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

5.  Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus.

Authors:  Sugandha Saboo; Ebenezer Tumban; Julianne Peabody; Denis Wafula; David S Peabody; Bryce Chackerian; Pavan Muttil
Journal:  Mol Pharm       Date:  2016-04-11       Impact factor: 4.939

6.  The impact of making vaccines thermostable in Niger's vaccine supply chain.

Authors:  Bruce Y Lee; Brigid E Cakouros; Tina-Marie Assi; Diana L Connor; Joel Welling; Souleymane Kone; Ali Djibo; Angela R Wateska; Lionel Pierre; Shawn T Brown
Journal:  Vaccine       Date:  2012-07-10       Impact factor: 3.641

7.  Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine.

Authors:  Dominique N Price; Nitesh K Kunda; Rajaun Ellis; Pavan Muttil
Journal:  Pharm Res       Date:  2019-12-23       Impact factor: 4.580

8.  Strategies for Vaccine Prioritization and Mass Dispensing.

Authors:  Eva K Lee; Zhuonan L Li; Yifan K Liu; James LeDuc
Journal:  Vaccines (Basel)       Date:  2021-05-14

9.  Optimized supply chain model reduces health system costs in DRC.

Authors:  Dorothy Thomas; Eomba Motomoke; Jessica Crawford; Olivier Defawe; Archimede Makaya; Jean Willy Ngwato; Joel Bompongo; Jose Monzembela; Gabriella Ailstock; Emily Bancroft; Bvudzai Magadzire; Dominique Baabo; Noel Watson
Journal:  Vaccine       Date:  2021-06-12       Impact factor: 3.641

10.  Augmenting transport versus increasing cold storage to improve vaccine supply chains.

Authors:  Leila A Haidari; Diana L Connor; Angela R Wateska; Shawn T Brown; Leslie E Mueller; Bryan A Norman; Michelle M Schmitz; Proma Paul; Jayant Rajgopal; Joel S Welling; Jim Leonard; Sheng-I Chen; Bruce Y Lee
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.